⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2163677 | 1.00 | — | — | |
| SCHEMBL9268696 | 0.77 | — | — | |
| SCHEMBL2590105 | 0.77 | — | — | |
| SCHEMBL2162883 | 0.75 | — | — | |
| SCHEMBL27451254 | 0.75 | — | — | |
| SCHEMBL2162888 | 0.75 | — | — | |
| SCHEMBL8596023 | 0.71 | — | — | |
| SCHEMBL2162589 | 0.71 | — | — | |
| SCHEMBL2162594 | 0.71 | — | — | |
| SCHEMBL10789600 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4371979-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024029475-A1 | WAVELENGTH CONVERSION FILM FORMING COMPOSITION | 日産化学株式会社 | 2024-02-08 | — | — | WO | disclosed |
| WO-2023286855-A1 | FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT | クミアイ化学工業株式会社 | 2023-01-19 | — | — | WO | disclosed |
| US-20200121652-A1 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | THE DOSHISHA (JP) | 2020-04-23 | — | — | US | disclosed |
| EP-3639855-A1 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | The Doshisha (JP) | 2020-04-22 | — | — | EP | disclosed |
| US-10326138-B2 | Charge storage material, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2019-06-18 | — | — | US | disclosed |
| EP-3122789-B1 | 9,10-BIS(1,3-DITHIOL-2-YLIDENE)-9,10-DIHYDROANTHRACENE POLYMERS AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2019-05-08 | — | — | EP | disclosed |
| US-10263280-B2 | 9,10-Bis(1,3-dithiol-2-ylidene)-9,10-dihydroanthracene polymers and use thereof | EVONIK DEGUSSA GMBH (DE) | 2019-04-16 | — | — | US | disclosed |
| US-10164258-B2 | Fused-ring quinone-substituted polynorbornene, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2018-12-25 | — | — | US | disclosed |
| US-20180244433-A1 | NON-CONTINUOUSLY LAMINATED STRUCTURES OF THERMOPLASTIC FILMS WITH DIFFERING MATERIAL COMPOSITIONS AND FUNCTIONAL MATERIAL PROPERTIES | THE GLAD PRODUCTS COMPANY | 2018-08-30 | — | — | US | disclosed |
| US-20030096335-A1 | Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds | PELZER STEFAN (DE) | 2003-05-22 | — | — | US | disclosed |
| US-6566110-B1 | Nucleotide sequences coding polypeptide for use tool in halogenating compounds | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-20 | — | — | US | disclosed |
| WO-2000077182-A9 | NUCLEIC ACID FRAGMENT AND VECTOR CONTAINING HALOGENASE AND METHOD FOR THE HALOGENATION OF CHEMICAL COMPOUNDS | BASF AG (DE) | 2002-09-12 | — | — | WO | disclosed |
| EP-1185629-A1 | NUCLEIC ACID FRAGMENT AND VECTOR CONTAINING HALOGENASE AND METHOD FOR THE HALOGENATION OF CHEMICAL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-13 | — | — | EP | disclosed |
| EP-1129207-A1 | CATALYTIC ANTIBODIES AND METHOD FOR PRODUCING CHROMANES BY CYCLIZATION WITH SAID ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-05 | — | — | EP | disclosed |
| EP-1123386-A1 | METHOD FOR PRODUCING CHIRAL CARBOXYLIC ACIDS FROM NITRILES WITH THE ASSISTANCE OF A NITRILASE OR MICROORGANISMS WHICH CONTAIN A GENE FOR THE NITRILASE | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-16 | — | — | EP | disclosed |
| WO-2000077182-A1 | NUCLEIC ACID FRAGMENT AND VECTOR CONTAINING HALOGENASE AND METHOD FOR THE HALOGENATION OF CHEMICAL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000028330-A1 | METHOD FOR SELECTING CATALYTIC ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000028063-A1 | CATALYTIC ANTIBODIES AND METHOD FOR PRODUCING CHROMANES BY CYCLIZATION WITH SAID ANTIBODIES | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000023577-A1 | METHOD FOR PRODUCING CHIRAL CARBOXYLIC ACIDS FROM NITRILES WITH THE ASSISTANCE OF A NITRILASE OR MICROORGANISMS WHICH CONTAIN A GENE FOR THE NITRILASE | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-27 | — | — | WO | disclosed |